1. AbbVie | Pharmaceutical Research & Development

Innovating for tomorrow.
Transforming lives today.

Allergan is now part of AbbVie. Together, we are dedicating more to R&D to drive tomorrow’s breakthroughs, while helping people live better lives today. From respected employer practices to environmental stewardship, we are proud of the recognition we’ve received in the UK.

With the Allergan acquisition, we are bringing together over 30 brands and leadership positions to expand and diversify our product portfolio, whilst advance our innovative science pipeline that brings patients ground breaking medicines across a wide spectrum of therapeutic need/critical therapeutic areas.

We continue to build a sustainable company for the long term that will continue to make a remarkable impact on people’s lives. The acquisition of Allergan is a transformative move for AbbVie that will expand our reach to help address the needs of people and communities around the world. 
 

The new AbbVie will be a well-diversified leader in many important therapeutic categories, with both on-market and pipeline assets, and our financial strength will allow us to continue to invest in innovative science and continue to serve unmet medical needs of patients that rely upon us. I am proud of both organisations and look forward to the opportunities ahead

Richard A. Gonzalez, chairman and chief executive officer, AbbVie

Advancing our mission

Learn how the acquisition of Allergan allows us to better serve patients today and invest in medicines of the future.

Resources

AbbVie is currently reviewing all content on Allergan.com.  As we work through the successful integration of Allergan and consolidation of content, information will be updated.